Detail
LncRNA Name | lncRNA-LET |
Synonyms | NPTN-IT1, lncRNA-LET |
Region | GRCh38_15:73567012-73569294 Sequence |
Ensembl | ENSG00000281183 |
RefSeq | NR_103844 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | bladder cancer |
ICD-0-3 | C67 |
Methods | qPCR, RIP, western blot etc. |
Sample | BC tissues, cell lines (T24, 5637, J82, SW780, BIU87, ScaBER and UMUC3) |
Expression Pattern | down-regulated |
Function Description | LET was the only lncRNA that was downregulated more than 2 folds in GEM-treated xenografts derived from both T24 and 5637 cells. The array results were further validated in these cell lines treated with or without GEM. reduced lncRNA-LET increased the NF90 protein stability, which in turn repressed biogenesis of miR-145 and subsequently resulted in accumulation of CSCs evidenced by the elevated levels of stemness markers HMGA2 and KLF4. UBC patients which displayed lower expression levels of lncRNA-LET and miR-145 had a reduced survival rate, whereas TGFB1 expression level did not show significant difference in clinical outcome. |
Pubmed ID | 28839463 |
Year | 2017 |
Title | TGFB1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer |
External Links |
Links for lncRNA-LET | GenBank HGNC lncrnadb Noncode |
Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.